Creekmur Asset Management LLC Has $440,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Creekmur Asset Management LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 47.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 888 shares of the medical equipment provider's stock after selling 799 shares during the period. Creekmur Asset Management LLC's holdings in Intuitive Surgical were worth $440,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in Intuitive Surgical during the 4th quarter worth about $2,401,493,000. GAMMA Investing LLC increased its stake in Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Capital Research Global Investors raised its holdings in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after buying an additional 494,496 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. Citigroup reaffirmed a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. BTIG Research set a $566.00 price objective on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday. Finally, Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $592.86.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the sale, the executive vice president directly owned 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This represents a 3.47% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,998 shares of company stock valued at $2,611,577. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $2.46 during mid-day trading on Friday, hitting $518.62. 1,903,997 shares of the company were exchanged, compared to its average volume of 1,676,454. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market capitalization of $185.88 billion, a P/E ratio of 76.04, a PEG ratio of 5.47 and a beta of 1.64. The business's 50 day simple moving average is $536.26 and its two-hundred day simple moving average is $536.13.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the previous year, the company posted $1.50 EPS. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.